Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of clinical outcomes between biodegradable polymer sirolimus-eluting stents and durable polymer everolimus-eluting stents in octogenarian patients.

Journal of cardiology·2026
Same author

Cathelicidin Links Visceral Fat Accumulation and Coronary Artery Disease.

Circulation journal : official journal of the Japanese Circulation Society·2026
Same author

Therapeutic ultrasound for acute myocardial infarction: Mechanisms, preclinical evidence, and clinical perspectives.

Journal of cardiology·2026
Same author

Performance Evaluation of Large Language Models With Retrieval-Augmented Generation in Cardiology Specialist Examinations in Japan.

Circulation reports·2025
Same author

Angiographic No-Reflow in Patients With Acute Coronary Syndrome Caused by Calcified Nodules.

The American journal of cardiology·2025
Same author

Discovery of fibroblast growth factor 2-derived peptides for enhancing mice skeletal muscle satellite cell proliferation.

Biotechnology journal·2024

Related Experiment Video

Updated: Jun 16, 2026

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy
11:51

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

Engineering a controlled cardiac multilineage co-differentiation process using statistical design of experiments.

Hirokazu Akiyama1, Yosuke Katayama2, Kazunori Shimizu2

  • 1Department of Biomolecular Engineering, Graduate School of Engineering, Nagoya University, Furo-cho, Chikusa-ku, Nagoya, 464-8603, Japan. akiyama.hirokazu.j2@f.mail.nagoya-u.ac.jp.

Stem Cell Research & Therapy
|June 2, 2025
PubMed
Summary

This study developed a controlled method for co-differentiating induced pluripotent stem cells (iPSCs) into multiple heart cell types. The strategy ensures precise cellular proportions for regenerative medicine and drug discovery applications.

Keywords:
Cardiac co-differentiationDesign of experimentsMulti-response modelingPluripotent stem cellsProcess engineering

More Related Videos

A Live-cell Image-Based Machine Learning Strategy to Monitor Pluripotent Stem Cell Differentiation
11:38

A Live-cell Image-Based Machine Learning Strategy to Monitor Pluripotent Stem Cell Differentiation

Published on: October 4, 2024

Designing a Bioreactor to Improve Data Acquisition and Model Throughput of Engineered Cardiac Tissues
12:28

Designing a Bioreactor to Improve Data Acquisition and Model Throughput of Engineered Cardiac Tissues

Published on: June 2, 2023

Related Experiment Videos

Last Updated: Jun 16, 2026

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy
11:51

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

A Live-cell Image-Based Machine Learning Strategy to Monitor Pluripotent Stem Cell Differentiation
11:38

A Live-cell Image-Based Machine Learning Strategy to Monitor Pluripotent Stem Cell Differentiation

Published on: October 4, 2024

Designing a Bioreactor to Improve Data Acquisition and Model Throughput of Engineered Cardiac Tissues
12:28

Designing a Bioreactor to Improve Data Acquisition and Model Throughput of Engineered Cardiac Tissues

Published on: June 2, 2023

Area of Science:

  • Stem Cell Biology
  • Cardiovascular Research
  • Regenerative Medicine

Background:

  • The heart comprises diverse cell types critical for its function, homeostasis, and disease.
  • Co-differentiating induced pluripotent stem cells (iPSCs) into multiple cardiac cell types offers potential for regenerative medicine and drug development.
  • Controlling the complex iPSC co-differentiation process to achieve desired cellular outcomes remains a significant challenge.

Purpose of the Study:

  • To engineer a robust and controllable strategy for the co-differentiation of iPSCs into major cardiac cell types: cardiomyocytes, mural cells, and endothelial cells.
  • To optimize the co-differentiation process for achieving specific heterotypic cellular proportions essential for proper cell-cell interactions.
  • To enhance the applicability of iPSC-based cardiac cell generation for regenerative medicine and pharmaceutical research.

Main Methods:

  • A two-stage strategy was employed: progenitor cell induction followed by trilineage co-differentiation.
  • Statistical design of experiments, including sequential optimization, was used to fine-tune differentiation factors like activin A and CHIR-99021.
  • Multi-response models were developed to delineate trilineage ratios based on WNT signal inhibitor and vascular endothelial growth factor concentrations.

Main Results:

  • Achieved approximately 95% induction efficiency of KDR+/PDGFR-α+ cardiogenic mesoderm cells from iPSCs with minimal batch-to-batch variability.
  • Demonstrated high process controllability in trilineage co-differentiation, with actual differentiation ratios closely matching predictions.
  • Cardiomyocytes derived from trilineage co-differentiation showed a more mature sarcomere gene expression profile compared to monolineage differentiation.

Conclusions:

  • The developed strategy effectively engineers a controlled stem cell co-differentiation process.
  • The method allows for precise control over cellular constitutions, crucial for applications requiring multicellular interactions.
  • This approach holds significant promise for advancing regenerative medicine and drug development by providing functional cardiac cell models.